| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Lag Time Epinephrine 10 ug/ml Aggregation | phv00259708.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Whole Blood: beta-thromboglobulin collagen alpha granule release (corrected for platelet count) | phv00259714.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Mean corpuscular hemoglobin concentration | phv00259631.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Age | phv00259608.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | PRP: Reversible Aggregation for ADP 2 uM | phv00259711.v1.p1 |
| This subject sample mapping file contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use. | Sample ID | phv00259605.v1.p1 |
| The pedigree table includes family ID, subject ID, father and mother ID, and subject gender, to link subjects of the same family. | Mother's Subject ID | phv00259602.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Slope ADP 10 uM Aggregation | phv00259685.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Slope AA 1 mM Aggregation | phv00259682.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Epinephrine 2 ug/ml Aggregation | phv00259679.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Whole Blood: Collagen 5 ug/ml Aggregation | phv00259653.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Whole Blood: Arachidonic Acid 0.5 mM + ASA 20 mM | phv00259656.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Whole Blood: ATP Release Collagen 5 ug/ml Aggregation corrected for platelet count | phv00259650.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Whole Blood: ATP Release Arachidonic Acid 0.5 mM corrected for platelet count | phv00259647.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | White blood cell count | phv00259624.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet count | phv00259627.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Total cholesterol | phv00259618.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Lag Time ADP 2 uM Aggregation | phv00259698.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | LDL cholesterol (calculated using Friedewald formula) | phv00259621.v1.p1 |
| The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status. | Platelet Rich Plasma: Lag Time Collagen 0.5 ug/ml Aggregation | phv00259701.v1.p1 |